The Huffington Post is a popular online source for not only news but opinion columns, editorials, and other digital content. As such they invest highly in getting the most experienced and knowledgeable people to write for them. That is why it set off quite a stir in the financial and business communities when Angela Koch earned a writing profile on their site.
Angela or “Angie” Koch is the current head of the U.S Money Reserve. Their organization is the single largest privately owned distributer of valuable metal products. This includes coins, bars, and other physical assets made from gold, silver, or platinum.
According to Ispot.tv and Glassdoor, As CEO of the U.S Money Reserve she has played a major role in the organizations steady rise to success after the market crash only a few years back. Sensing the loss in consumer confidence the crash had triggered, The U.S Money Reserve began pushing its assets to individuals and businesses alike as a method of adding diversity and physical security to all their investments.
Koch has a long history in the world of strategy and business planning earned from first-hand experience at the U.S Money Reserve as well as other organizations. Now that knowledge will be available to Huffington Post readers with each article she publishes on the site.
According to Koch she has had a life long interest in cultivating opportunity and value and is eager to share her experiences with the Huffington Posts large and diverse audience.
As such, her very first post on the site was titled,” Three Ways the Political Conventions Empowered Women.” It charted critical moments from both conventions that showed women taking decisive leadership roles.
Offering a unique combination of first-hand business experience, distinctive perspective, and a charismatic personality Angela Koch is sure to make a solid addition to the Huffington Post staff of regular contributors.
Decades have passed with a strong push for a cure for cancer, yet despite the amount of money that has been raised for finding a cure, it has never come to fruition. Seattle Genetics, a company that has pioneered antibody-based therapies. These therapies have been heavily researched for the sole purpose of killing cancer cells. While many different drugs have come to the forefront, this time, Seattle Genetics may be the winner.
Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript
Additionally, the highlight of this type of therapy is that it is designed to spare those cells that are non-cancerous. The main goal that has been set in order to raise the bar on more holistic therapies, is that chemotherapy would no longer be deemed the first choice for cancer patients. The miracle of meeting unmet needs in the medical field would be an accomplishment, but additionally, it would epitome of medical research as we know it.
These drugs, known as antibody-drug conjugates, or ADC’s, are making headlines as the research and trials continue with the company. This could means that these drugs could potentially become the anti-tumor solution that doctors and patients have been searching for. The treatment level for cancer thus far has included various types of lymphomas include CD30-expressing lymphomas, Hodgkin’s lymphoma, cutaneous T-cell lymphoma, and many others.
Additional trials will also include an ADC that is designed to target various other types of cancers including leukemia, hematologic malignancies, and various types of tumors. The clinical research and trials that are being run by Clay Siegall at
I just decided that I should start investing as much as I could, and that is when I went over to Laidlaw & Company to get help. They have been really great to me, and I am getting such good results even though all I am doing is following simple instructions. I talked to James Ahern and Matthew Eitner on two different occasions, and now I am ready to spend my money in the right places. They suggested that I go for a business investment that would make me part owner of a company they work with, and I started it immediately.
U.S. Federal Court Issues Temporary Restraining Order Against Laidlaw & Company And Its Principals Matthew Eitner And James Ahern
I got invested in this company that was really interesting to me, and I took over a 50% stake in it when it was still young. What happened was that I gave them the money that they needed to keep going, but now I own half a business that is doing really well. I just get the reports from my broker, and then I can see how well they are doing.
I am getting more advice from the Laidlaw & Company team every week because they have a lot of good ideas for me. The best thing that I can do is just to make sure that I am saving as much money as I can to be sure that I can retire well. I want to invest in other companies, and I like the fact that I can keep doing this for as long as I want. I like the way my investments are working because they are not that complicated.
Seattle Genetics is well on sales for three very good reasons. The first is their leader Clay Siegall who is a geneticist who has been working on their antibody based drugs for a long time. He is also a great marketer of his product because he had to get it to as many people as possible. That meant that he has to be a salesman, and it has worked for him really well. His company is also getting results for patients who have cancer. They are selling to doctors who know that their products work, and that means that they are saving people who would have been in trouble otherwise.
Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript
The best part of the equation for Seattle Genetics is that they are helping people who have common types of cancer that have not been treated as well in the past. They are looking at lymphoma and other kinds of cancer trying to treat them, and then they can do other kinds of drugs if they want.
A company that is selling nearly $100 million a year in medication usually has a lot of different drugs, but Seattle Genetics is targeting the market with just two. That means that the people who are looking for a new kind of drug should at least think of trying Seattle Genetics. This makes it a lot easier for everyone to get better, and it gives them hope.
There are meeting notes online that people can read showing how well the people using the drugs are doing, and it shows that their company is reaching out to more doctors every day. They could sell over $100 million in the next year, and they will have a chance to help more people. They are still in trials, but they are making the best go of it that they can.
Securus Technologies has recently exposed an integrity breach in the telecommunications industry by a company known as GTL. The company has found out that GTL has taken advantage of manipulating rates of phone use in correctional facilities in Louisiana. Due to this price manipulation, Securus is looking to make sure that these breaches never occur again and is therefore looking to inform the public about unethical conduct by rival company GTL. Along with informing the public about this integrity breach, Securus Technologies will investigate the situation themselves and look for ways to help restore ethical practices for GTL in the telecommunications industry.
Read more at Wikipedia about Securus.
Recently, Securus has exposed wrongdoing by GTL in terms of phone use rate manipulation. One of the first things that Securus Technologies found out was that the company Global Tell Link programmed clocks on phones at correctional facilities which would at an additional 36 seconds per call. As a result this led to the company increasing its revenues in an unauthorized manner. Due to this being unlawful and unauthorized, Securus is looking to find a way to end this practice immediately. Another discovery in terms of unethical conduct by Global Tel Link is that they would charge rates higher than allowed in order to boost revenue. The company artificially inflated its charges and therefore took advantage of facilities phone use. Global Tel Link has also charged the same call multiple times as well.
Due to these practices being both illegal and unethical, Securus Technologies has been willing to assist the Louisiana Department of Corrections in putting an end to this conduct. Therefore Securus has decided to provide a comprehensive report on the unethical conduct by Global Tel Link and try to convince the company to stop manipulating phone charges in the various correctional facilities in the state of Louisiana.
Securus Video Visitation – Kids from Securus Technologies on Vimeo.